Skip to main content
. 2020 May 15;11:2417. doi: 10.1038/s41467-020-15922-5

Table 4.

Percent of motile wildtype and mutant actin–Tpm filaments determined from in vitro analysis.

Filament type ±Tpm [Myosin] (µg ml−1) Filaments moving (%) n
F-Act88FWT 12.5 31.02 ± 1.64 22
F-Act88FM305L 12.5 32.57 ± 2.34 21
F-Act88FWT + 12.5 14.96 ± 1.49 20
F-Act88FM305L + 12.5 21.17 ± 2.11* 21
F-Act88FWT 50 68.11 ± 1.51 16
F-Act88FM305L 50 68.00 ± 2.30 20
F-Act88FWT + 50 56.43 ± 1.04 21
F-Act88FM305L + 50 67.81 ± 1.37# 21
F-Act88FWT 100 64.09 ± 1.64 19
F-Act88FM305L 100 67.89 ± 1.61 22
F-Act88FWT + 100 62.87 ± 1.83 20
F-Act88FM305L + 100 71.16 ± 1.78** 22

Data are presented as mean ± SEM. *P≤0.05, **P≤0.01, #P≤0.0001 Significantly different from F-Act88FWT+Tpm. Significant differences between filament types ± Tpm at each myosin concentration were assessed using a two-way ANOVA with Bonferroni post-tests. Source data are provided as a Source Data file.